227 related articles for article (PubMed ID: 15328377)
21. [The effect of aflatoxin B1 on vitamin A status and on microsomal mixed function oxidase in male mouse].
Liu XL; Zhou YZ
Zhonghua Yu Fang Yi Xue Za Zhi; 1989 Jul; 23(4):218-21. PubMed ID: 2516794
[TBL] [Abstract][Full Text] [Related]
22. Determination of the role of target tissue metabolism in lung carcinogenesis using conditional cytochrome P450 reductase-null mice.
Weng Y; Fang C; Turesky RJ; Behr M; Kaminsky LS; Ding X
Cancer Res; 2007 Aug; 67(16):7825-32. PubMed ID: 17699788
[TBL] [Abstract][Full Text] [Related]
23. Impact of liver P450 reductase suppression on cyclophosphamide activation, pharmacokinetics and antitumoral activity in a cytochrome P450-based cancer gene therapy model.
Huang Z; Raychowdhury MK; Waxman DJ
Cancer Gene Ther; 2000 Jul; 7(7):1034-42. PubMed ID: 10917206
[TBL] [Abstract][Full Text] [Related]
24. A transgenic mouse expressing human CYP4B1 in the liver.
Imaoka S; Hayashi K; Hiroi T; Yabusaki Y; Kamataki T; Funae Y
Biochem Biophys Res Commun; 2001 Jun; 284(3):757-62. PubMed ID: 11396967
[TBL] [Abstract][Full Text] [Related]
25. Immunochemical characterization of multiple forms of cytochrome P-450 in rabbit nasal microsomes and evidence for tissue-specific expression of P-450s NMa and NMb.
Ding XX; Coon MJ
Mol Pharmacol; 1990 Apr; 37(4):489-96. PubMed ID: 2109181
[TBL] [Abstract][Full Text] [Related]
26. Effect of perinatal low protein diets on the ontogeny of select hepatic cytochrome p450 enzymes and cytochrome p450 reductase in the rat.
Cherala G; Shapiro BH; D'mello AP
Drug Metab Dispos; 2007 Jul; 35(7):1057-63. PubMed ID: 17392395
[TBL] [Abstract][Full Text] [Related]
27. Expression of hepatic and ovarian cytochrome P450 during estrous cycle in rats.
Lee SY; Oh SJ; Yun KU; Kim HM; Kim BH; Lee K; Kim SK
Arch Toxicol; 2012 Jan; 86(1):75-85. PubMed ID: 21717108
[TBL] [Abstract][Full Text] [Related]
28. Effects of the anticancer dehydrotarplatin on cytochrome P450 and antioxidant enzymes in male rat tissues.
Nannelli A; Messina A; Marini S; Trasciatti S; Longo V; Gervasi PG
Arch Toxicol; 2007 Jul; 81(7):479-87. PubMed ID: 17364183
[TBL] [Abstract][Full Text] [Related]
29. Regulation of intestinal cytochrome P450 expression by hepatic cytochrome P450: possible involvement of fibroblast growth factor 15 and impact on systemic drug exposure.
Zhu Y; Ding X; Fang C; Zhang QY
Mol Pharmacol; 2014 Jan; 85(1):139-47. PubMed ID: 24184963
[TBL] [Abstract][Full Text] [Related]
30. Cytochrome P450 and steroid hydroxylase activity in mouse olfactory and vomeronasal mucosa.
Gu J; Dudley C; Su T; Spink DC; Zhang QY; Moss RL; Ding X
Biochem Biophys Res Commun; 1999 Dec; 266(1):262-7. PubMed ID: 10581200
[TBL] [Abstract][Full Text] [Related]
31. In vivo mechanisms of tissue-selective drug toxicity: effects of liver-specific knockout of the NADPH-cytochrome P450 reductase gene on acetaminophen toxicity in kidney, lung, and nasal mucosa.
Gu J; Cui H; Behr M; Zhang L; Zhang QY; Yang W; Hinson JA; Ding X
Mol Pharmacol; 2005 Mar; 67(3):623-30. PubMed ID: 15550675
[TBL] [Abstract][Full Text] [Related]
32. High diversity and complex evolution of fungal cytochrome P450 reductase: cytochrome P450 systems.
Lah L; Krasevec N; Trontelj P; Komel R
Fungal Genet Biol; 2008 Apr; 45(4):446-58. PubMed ID: 18024101
[TBL] [Abstract][Full Text] [Related]
33. Biochemical characteristics of purified beef liver NADPH-cytochrome P450 reductase.
Arinç E; Celik H
J Biochem Mol Toxicol; 2002; 16(6):286-97. PubMed ID: 12481304
[TBL] [Abstract][Full Text] [Related]
34. Effects of dioxane on cytochrome P450 enzymes in liver, kidney, lung and nasal mucosa of rat.
Nannelli A; De Rubertis A; Longo V; Gervasi PG
Arch Toxicol; 2005 Feb; 79(2):74-82. PubMed ID: 15490126
[TBL] [Abstract][Full Text] [Related]
35. Determination of phase I metabolic enzyme activities in liver microsomes of Mrp2 deficient TR- and EHBR rats.
Newton DJ; Wang RW; Evans DC
Life Sci; 2005 Jul; 77(10):1106-15. PubMed ID: 15913659
[TBL] [Abstract][Full Text] [Related]
36. CYP3A5-mediated metabolism of midazolam in recombinant systems is highly sensitive to NADPH-cytochrome P450 reductase activity.
Christensen H; Hestad AL; Molden E; Mathiesen L
Xenobiotica; 2011 Jan; 41(1):1-5. PubMed ID: 20954901
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of isoflavone synthase activity by co-expression of P450 reductase from rice.
Kim DH; Kim BG; Lee HJ; Lim Y; Hur HG; Ahn JH
Biotechnol Lett; 2005 Sep; 27(17):1291-4. PubMed ID: 16215827
[TBL] [Abstract][Full Text] [Related]
38. Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase.
Henderson CJ; Otto DM; Carrie D; Magnuson MA; McLaren AW; Rosewell I; Wolf CR
J Biol Chem; 2003 Apr; 278(15):13480-6. PubMed ID: 12566435
[TBL] [Abstract][Full Text] [Related]
39. In vivo induction of human cytochrome P450 enzymes expressed in chimeric mice with humanized liver.
Katoh M; Matsui T; Nakajima M; Tateno C; Soeno Y; Horie T; Iwasaki K; Yoshizato K; Yokoi T
Drug Metab Dispos; 2005 Jun; 33(6):754-63. PubMed ID: 15769886
[TBL] [Abstract][Full Text] [Related]
40. The disruption of hepatic cytochrome p450 reductase alters mouse lipid metabolism.
Mutch DM; Klocke B; Morrison P; Murray CA; Henderson CJ; Seifert M; Williamson G
J Proteome Res; 2007 Oct; 6(10):3976-84. PubMed ID: 17722906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
